(2S,5aS,8aR)-2-{3-[(2R)-2-(Methoxymethyl)-1-pyrrolidinyl]-3-oxopropyl}-1-methyl-6-(2-thienylmethyl)octahydropyrrolo[3,2-E][1,4]diazepin-5(2H)-one

ID: Reference10991

C₂₂H₃₄N₄O₃S

(2S,5aS,8aR)-2-[3-[(2R)-2-(Methoxymethyl)pyrrolidin-1-yl]-3-oxopropyl]-1-methyl-6-(thiophen-2-ylmethyl)-3,4,5a,7,8,8a-hexahydro-2H-pyrrolo[3,2-E][1,4]diazepin-5-one; Pyrrolo[3,2-E]-1,4-diazepin-5(2H)-one, octahydro-2-[3-[(2R)-2-(methoxymethyl)-1-pyrrolidinyl]-3-oxopropyl]-1-methyl-6-(2-thienylmethyl)-, (2S,5aS,8aR)-; NAT23-391277

(1R,9S)-11-(4-Fluorobenzoyl)-3-(2-thienyl)-7,11-diazatricyclo[7.3.1.0^2,7]trideca-2,4-dien-6-one

ID: Reference11025

C₂₂H₁₉FN₂O₂S

(1R,9S)-11-(4-Fluorobenzoyl)-3-thiophen-2-yl-7,11-diazatricyclo[7.3.1.02,7]trideca-2,4-dien-6-one; 1,5-Methano-8H-pyrido[1,2-a][1,5]diazocin-8-one, 3-(4-fluorobenzoyl)-1,2,3,4,5,6-hexahydro-11-(2-thienyl)-, (1R,5S)-; NAT11-287724

(6R)-N-Propyl-6-[4-(trifluoromethyl)phenoxy]-1,4-oxazepane-4-carboxamide

ID: Reference11174

C₁₆H₂₁F₃N₂O₃

(6R)-N-Propyl-6-[4-(trifluoromethyl)phenoxy]-1,4-oxazepane-4-carboxamide; 1,4-Oxazepine-4(5H)-carboxamide, tetrahydro-N-propyl-6-[4-(trifluoromethyl)phenoxy]-, (6R)-; NAT47-548945

(1S)-1,5-Anhydro-2,3,6-trideoxy-1-{[5-(4-fluorophenyl)-1,2-oxazol-3-yl]methyl}-6-(tetrahydro-2H-pyran-4-ylamino)-D-erythro-hexitol

ID: Reference11217

C₂₁H₂₇FN₂O₄

(2R,3S,6S)-6-[[5-(4-Fluorophenyl)-1,2-oxazol-3-yl]methyl]-2-[(oxan-4-ylamino)methyl]oxan-3-ol; D-Arabino-heptitol, 2,6-anhydro-1,3,4,7-tetradeoxy-1-[5-(4-fluorophenyl)-3-isoxazolyl]-7-[(tetrahydro-2H-pyran-4-yl)amino]-; NAT12-540403

(8aR)-7-[(6-Methoxy-3-pyridinyl)methyl]-2-phenylhexahydroimidazo[1,5-a]pyrazin-3(2H)-one

ID: Reference11308

C₁₉H₂₂N₄O₂

(8aR)-7-[(6-Methoxypyridin-3-yl)methyl]-2-phenyl-5,6,8,8a-tetrahydro-1H-imidazo[1,5-a]pyrazin-3-one; Imidazo[1,5-a]pyrazin-3(2H)-one, hexahydro-7-[(6-methoxy-3-pyridinyl)methyl]-2-phenyl-, (8aR)-; NAT50-556072

(8aR)-7-[(1-Methyl-1H-pyrazol-4-yl)methyl]-2-phenylhexahydroimidazo[1,5-a]pyrazin-3(2H)-one

ID: Reference11322

C₁₇H₂₁N₅O

(8aR)-7-[(1-Methylpyrazol-4-yl)methyl]-2-phenyl-5,6,8,8a-tetrahydro-1H-imidazo[1,5-a]pyrazin-3-one; Imidazo[1,5-a]pyrazin-3(2H)-one, hexahydro-7-[(1-methyl-1H-pyrazol-4-yl)methyl]-2-phenyl-, (8aR)-; NAT50-556074

(8aS)-N-(2-Methoxyphenyl)-3-oxohexahydroimidazo[1,5-a]pyrazine-7(1H)-carboxamide

ID: Reference11426

C₁₄H₁₈N₄O₃

(8aS)-N-(2-Methoxyphenyl)-3-oxo-1,2,5,6,8,8a-hexahydroimidazo[1,5-a]pyrazine-7-carboxamide; Imidazo[1,5-a]pyrazine-7(1H)-carboxamide, hexahydro-N-(2-methoxyphenyl)-3-oxo-, (8aS)-; NAT50-554155

(8aR)-7-(1H-Indol-3-ylmethyl)-2-methylhexahydroimidazo[1,5-a]pyrazin-3(2H)-one

ID: Reference11427

C₁₆H₂₀N₄O

(8aR)-7-(1H-Indol-3-ylmethyl)-2-methyl-5,6,8,8a-tetrahydro-1H-imidazo[1,5-a]pyrazin-3-one; Imidazo[1,5-a]pyrazin-3(2H)-one, hexahydro-7-(1H-indol-3-ylmethyl)-2-methyl-, (8aR)-; NAT50-557207

1,4-Anhydro-2,5-dideoxy-5-{[(4-methylphenyl)sulfonyl]amino}-2-(tetrahydro-2H-pyran-4-ylamino)-D-arabinitol

ID: Reference11504

C₁₇H₂₆N₂O₅S

N-[[(2R,3S,4R)-3-Hydroxy-4-(oxan-4-ylamino)oxolan-2-yl]methyl]-4-methylbenzenesulfonamide; D-Arabinitol, 1,4-anhydro-2,5-dideoxy-5-[[(4-methylphenyl)sulfonyl]amino]-2-[(tetrahydro-2H-pyran-4-yl)amino]-; NAT19-551659

1,4-Anhydro-2,5-dideoxy-5-[(4-fluorobenzoyl)amino]-2-(tetrahydro-2H-pyran-4-ylamino)-D-arabinitol

ID: Reference11544

C₁₇H₂₃FN₂O₄

4-Fluoro-N-[[(2R,3S,4R)-3-hydroxy-4-(oxan-4-ylamino)oxolan-2-yl]methyl]benzamide; D-Arabinitol, 1,4-anhydro-2,5-dideoxy-5-[(4-fluorobenzoyl)amino]-2-[(tetrahydro-2H-pyran-4-yl)amino]-; NAT19-551459

1,4-Anhydro-2,5-dideoxy-5-[(3,3-dimethylbutanoyl)amino]-2-(tetrahydro-2H-pyran-4-ylamino)-D-arabinitol

ID: Reference11665

C₁₆H₃₀N₂O₄

N-[[(2R,3S,4R)-3-Hydroxy-4-(oxan-4-ylamino)oxolan-2-yl]methyl]-3,3-dimethylbutanamide; D-Arabinitol, 1,4-anhydro-2,5-dideoxy-5-[(3,3-dimethyl-1-oxobutyl)amino]-2-[(tetrahydro-2H-pyran-4-yl)amino]-; NAT19-551059

1,4-Anhydro-2,5-dideoxy-5-[(4-morpholinylcarbonyl)amino]-2-(tetrahydro-2H-pyran-4-ylamino)-D-arabinitol

ID: Reference11666

C₁₅H₂₇N₃O₅

N-[[(2R,3S,4R)-3-Hydroxy-4-(oxan-4-ylamino)oxolan-2-yl]methyl]morpholine-4-carboxamide; D-Arabinitol, 1,4-anhydro-2,5-dideoxy-5-[(4-morpholinylcarbonyl)amino]-2-[(tetrahydro-2H-pyran-4-yl)amino]-; NAT19-551859